-
- Homepage for Indication Selection
-
- Patient Homepage for Melanoma Indication
-
- New Approved Indication – Patient Homepage
-
- HCP Homepage for New Approved Indication
-
- HCP Homepage for Melanoma Indication
Keytruda Now Approved Website
Brand: Keytruda (pembrolizumab), Injection
Parent Company: Merck
Drug Type: Prescription
Drug Category: Oncology
Campaign: now-approved, Launch
Targeting: HCPs, Patients
Patient Website: https://www.keytruda.com/
HCP Website: https://www.keytruda.com/hcp/